Medical digital imaging market seen reaching $35.38 billion by 2030
The Business Research Company says the medical digital imaging system market is expected to grow from $27.15 billion in 2026 to $35.38 billion by 2030, driven by demand for portable imaging, AI tools and telemedicine. North America led the market in 2025, while Asia-Pacific is projected to grow the fastest.
Why it matters: - Medical digital imaging is becoming more central to diagnosis, treatment planning and disease monitoring as healthcare providers move away from analog systems. - The market’s growth points to rising demand for faster, more precise imaging across hospitals, diagnostic centers and point-of-care settings. - Lifestyle diseases and an aging population are adding pressure for more imaging capacity and smarter workflows.
What happened: - The Business Research Company projected the medical digital imaging system market will rise from $27.15 billion in 2026 to $35.38 billion by 2030. - The report said the market grew from $25.33 billion in 2025 to $27.15 billion in 2026, a 7.2% CAGR. - The release said North America held the largest market share in 2025, while Asia-Pacific is expected to post the fastest growth during the forecast period. - The report covered Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The company released a free sample of the report at the sample report and the full report at the full market report.
The details: - Medical digital imaging systems use hardware and software to capture, store, process and display medical images digitally. - The systems include modalities such as X-ray and positron emission tomography, or PET. - The technology supports clinical decisions by helping providers diagnose, monitor and plan treatment. - The report linked near-term growth to digital imaging replacing analog systems, higher rates of chronic disease, imaging sensor advances, higher healthcare spending in developed countries and more diagnostic imaging centers. - The report tied longer-term growth to portable and point-of-care imaging devices, AI-assisted diagnostic decisions, telemedicine and teleradiology, an older patient population and cloud-based imaging and storage. - The report highlighted AI-enhanced diagnostic precision, cloud-based imaging platforms, EHR and EMR integration, tele-radiology, and smaller, more portable devices as key trends. - The release said lifestyle-related diseases are a major driver of demand because imaging helps with early detection and more precise diagnosis. - A June 2024 UK National Health Service data point showed 3,615,330 patients registered with general practitioners were diagnosed with non-diabetic hyperglycemia in 2023, up 18% from 3,065,825 in 2022.
Between the lines: - The market outlook suggests imaging is shifting from a standalone diagnostic tool to a connected data platform tied to cloud systems, AI and electronic records. - The regional growth split suggests mature markets are still large, but faster expansion is moving toward regions with rising healthcare investment and demand. - The focus on lifestyle disease reflects a broader care trend: more chronic conditions mean more screening, monitoring and repeat imaging.
What's next: - The market is forecast to keep expanding through 2030 as providers adopt portable devices, AI-enabled workflows and cloud storage. - Telemedicine and teleradiology adoption should continue to support remote interpretation and broader access to imaging services. - Product development is likely to emphasize portability, interoperability and faster decision support. - The Business Research Company also said its 2026 reports include market attractiveness scoring, TAM analysis, company scoring matrix graphics, Excel-based forecasting dashboards and updated trend visuals.
The bottom line: - Medical digital imaging is moving deeper into digital care delivery, and the growth outlook depends on AI, portability and connected clinical systems.
Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.
Sign up for:
Today in Medicine
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.